149 related articles for article (PubMed ID: 17680814)
21. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.
Roemer E; Blau IW; Basara N; Kiehl MG; Bischoff M; Günzelmann S; Kirsten D; Sanchez H; Wocker EL; Fauser AA
Clin Infect Dis; 2001 Jan; 32(1):E1-8. PubMed ID: 11118397
[TBL] [Abstract][Full Text] [Related]
22. [Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid].
Inaba A; Koh H; Nakashima Y; Nishimoto M; Hayashi Y; Okamura H; Inoue A; Nanno S; Nakane T; Shimono T; Nakamae H; Hino M
Rinsho Ketsueki; 2014 Apr; 55(4):456-60. PubMed ID: 24850458
[TBL] [Abstract][Full Text] [Related]
23. Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation.
Megged O; Shalit I; Yaniv I; Stein J; Fisher S; Levy I
Pediatr Transplant; 2008 Dec; 12(8):902-5. PubMed ID: 18194354
[TBL] [Abstract][Full Text] [Related]
24. [Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia].
Hirate T; Kitazawa H; Sakaguchi H; Akita N; Hasegawa C; Yamamoto K; Kutsuna S; Mikita K; Mori T; Hama A; Yoshida N
Rinsho Ketsueki; 2023; 64(10):1275-1279. PubMed ID: 37914240
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques.
Fricker-Hidalgo H; Bulabois CE; Brenier-Pinchart MP; Hamidfar R; Garban F; Brion JP; Timsit JF; Cahn JY; Pelloux H
Clin Infect Dis; 2009 Jan; 48(2):e9-e15. PubMed ID: 19072243
[TBL] [Abstract][Full Text] [Related]
26. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients.
Sumi M; Aosai F; Norose K; Takeda W; Kirihara T; Sato K; Fujikawa Y; Shimizu I; Ueki T; Hirosima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Int J Hematol; 2013 Aug; 98(2):214-22. PubMed ID: 23749548
[TBL] [Abstract][Full Text] [Related]
27. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
[TBL] [Abstract][Full Text] [Related]
28. Toxoplasmosis after hematopoietic stem cell transplantation.
Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
[TBL] [Abstract][Full Text] [Related]
30. Atypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency.
Stajner T; Vasiljević Z; Vujić D; Marković M; Ristić G; Mićić D; Pasić S; Ivović V; Ajzenberg D; Djurković-Djaković O
J Clin Microbiol; 2013 Aug; 51(8):2686-90. PubMed ID: 23761151
[TBL] [Abstract][Full Text] [Related]
31. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasma encephalitis in an allogeneic hematopoietic stem cell transplant recipient in Korea.
Park SK; Choi JK; Yoo C; Park SJ; Lee TH; Lee JH; Kim SH
Korean J Intern Med; 2012 Jun; 27(2):235-8. PubMed ID: 22707900
[No Abstract] [Full Text] [Related]
33. Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients.
Schwenk HT; Khan A; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis DG
Transplant Cell Ther; 2021 Apr; 27(4):292-300. PubMed ID: 33840441
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.
Antinori A; Ammassari A; De Luca A; Cingolani A; Murri R; Scoppettuolo G; Fortini M; Tartaglione T; Larocca LM; Zannoni G; Cattani P; Grillo R; Roselli R; Iacoangeli M; Scerrati M; Ortona L
Neurology; 1997 Mar; 48(3):687-94. PubMed ID: 9065549
[TBL] [Abstract][Full Text] [Related]
35. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
36. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients.
Bretagne S; Costa JM; Foulet F; Jabot-Lestang L; Baud-Camus F; Cordonnier C
Transpl Infect Dis; 2000 Sep; 2(3):127-32. PubMed ID: 11429023
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
Brinkman K; Debast S; Sauerwein R; Ooyman F; Hiel J; Raemaekers J
Bone Marrow Transplant; 1998 Mar; 21(6):635-6. PubMed ID: 9543070
[TBL] [Abstract][Full Text] [Related]
39. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
Aerts R; Mehra V; Groll AH; Martino R; Lagrou K; Robin C; Perruccio K; Blijlevens N; Nucci M; Slavin M; Bretagne S; Cordonnier C;
Lancet Infect Dis; 2024 May; 24(5):e291-e306. PubMed ID: 38134949
[TBL] [Abstract][Full Text] [Related]
40. Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
Lim Z; Baker B; Zuckerman M; Wade JJ; Ceesay M; Ho AY; Devereux S; Mufti GJ; Pagliuca A
J Infect; 2007 Feb; 54(2):e83-6. PubMed ID: 16806484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
